Dubash, Sayam et al
"Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis." Clinical Medicine
19.Suppl 2
(2019):
106-107.
Web. 18 April. 2024.
